Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Dec 30;15(12):7159-7161.
doi: 10.21037/jtd-23-1394. Epub 2023 Dec 6.

Future expectations for respiratory disease assessment in dynamic chest radiography

Affiliations
Editorial

Future expectations for respiratory disease assessment in dynamic chest radiography

Jun Hanaoka. J Thorac Dis. .
No abstract available

Keywords: Dynamic chest radiography (DCR); cystic fibrosis (CF); whole-body plethysmography (WBP).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1394/coif). The author has no conflicts of interest to declare.

Comment on

Similar articles

References

    1. FitzMaurice TS, McCann C, Nazareth D, et al. Feasibility of dynamic chest radiography to calculate lung volumes in adult people with cystic fibrosis: a pilot study. BMJ Open Respir Res 2023;10:e001309. 10.1136/bmjresp-2022-001309 - DOI - PMC - PubMed
    1. Tanaka R. Dynamic chest radiography: flat-panel detector (FPD) based functional X-ray imaging. Radiol Phys Technol 2016;9:139-53. 10.1007/s12194-016-0361-6 - DOI - PubMed
    1. Quon BS, Aitken ML. Cystic fibrosis: what to expect now in the early adult years. Paediatr Respir Rev 2012;13:206-14. 10.1016/j.prrv.2012.03.005 - DOI - PubMed
    1. Schluchter MD, Konstan MW, Drumm ML, et al. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 2006;174:780-6. 10.1164/rccm.200512-1919OC - DOI - PMC - PubMed
    1. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994;331:637-42. 10.1056/NEJM199409083311003 - DOI - PubMed